首页> 美国卫生研究院文献>Biomolecules Therapeutics >Xanthoangelol and 4-Hydroxyderricin Are the Major Active Principles of the Inhibitory Activities against Monoamine Oxidases on Angelica keiskei K
【2h】

Xanthoangelol and 4-Hydroxyderricin Are the Major Active Principles of the Inhibitory Activities against Monoamine Oxidases on Angelica keiskei K

机译:黄嘌呤醇和4-羟基derricin是抑制当归keiskei K单胺氧化酶活性的主要活性原理

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Monoamine oxidase inhibitors (MAOI) have been widely used as antidepressants. Recently, there has been renewed interest in MAO inhibitors. The activity-guided fractionation of extracts from Angelica keiskei Koidzumi (A. keiskei K.) led to the isolation of two prenylated chalcones, xanthoangelol and 4-hydroxyderricin and a flavonoid, cynaroside. These three isolated compounds are the major active ingredients of A. keiskei K. to inhibit the MAOs and DBH activities. Xanthoangelol is a nonselective MAO inhibitor, and a potent dopamine β-hydroxylase (DBH) inhibitor. IC50 values of xanthoangelol to MAO-A and MAO-B were calculated to be 43.4 μM, and 43.9 μM. These values were very similar to iproniazid, which is a nonselective MAO inhibitor used as a drug against depression. The IC50 values of iproniazid were 37 μM, and 42.5 μM in our parallel examination. Moreover, IC50 value of xanthoangelol to DBH was calculated 0.52 μM. 4-Hydroxyderricin is a potent selective MAO-B inhibitor and also mildly inhibits DBH activity. The IC50 value of 4-hydroxyderricin to MAO-B was calculated to be 3.43 μM and this value was higher than that of deprenyl (0.046 μM) used as a positive control for selective MAO-B inhibitor in our test. Cynaroside is a most potent DBH inhibitor. The IC50 value of cynaroside to DBH was calculated at 0.0410 μM. Results of this study suggest that the two prenylated chalcones, xanthoangelol and 4-hydroxyderricin isolated from A. keiskei K., are expected for potent candidates for development of combined antidepressant drug. A. keiskei K. will be an excellent new bio-functional food material that has the combined antidepressant effect.
机译:单胺氧化酶抑制剂(MAOI)已被广泛用作抗抑郁药。最近,人们对MAO抑制剂有了新的兴趣。以当归提取物的活性为导向进行分级分离,从而分离出两个异戊二烯基查耳酮,黄嘌呤酚和4-羟基derricin,以及一种类黄酮,Cynaroside。这三种分离的化合物是ke.keiskei K.抑制MAO和DBH活性的主要活性成分。黄嘌呤醇是一种非选择性的MAO抑制剂,也是一种有效的多巴胺β-羟化酶(DBH)抑制剂。黄嘌呤醇对MAO-A和MAO-B的IC 50值经计算为43.4μM和43.9μM。这些值与异丙肾上腺素非常相似,后者是一种非选择性的MAO抑制剂,可用作抗抑郁药。在我们的平行检查中,异烟肼的IC50值分别为37μM和42.5μM。此外,黄嘌呤酚对DBH的IC 50值计算为0.52μM。 4-羟基derricin是一种有效的选择性MAO-B抑制剂,也可以轻度抑制DBH活性。计算得出4-羟基derricin对MAO-B的IC50值为3.43μM,该值高于在我们的测试中用作选择性MAO-B抑制剂阳性对照的异戊二烯基(0.046μM)。 Cynaroside是最有效的DBH抑制剂。肉桂醛对DBH的IC50值经计算为0.0410μM。这项研究的结果表明,从A. keiskei K.分离出的两个烯丙基化查耳酮,黄嘌呤酚和4-羟基derricin有望成为开发抗抑郁药的有效候选药物。 A. keiskei K.将是一种出色的新型生物功能食品,具有综合的抗抑郁作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号